Terms: = Liver cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359
81 results:
1. Regucalcin downregulation in human cancer.
Ghanem NZ; Yamaguchi M
Life Sci; 2024 Mar; 340():122448. PubMed ID: 38246519
[TBL] [Abstract] [Full Text] [Related]
2. EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular Characterization.
Baber A; Legendre P; Palmic P; Lupo-Mansuet A; Burroni B; Azoulay C; Szwebel TA; Costedoat-Chalumeau N; Leroy K; Blons H; Blay JY; Boudou-Rouquette P; Terrier B
Int J Surg Pathol; 2024 Feb; 32(1):150-154. PubMed ID: 37157817
[TBL] [Abstract] [Full Text] [Related]
3. Neurofibromatosis Type 1 with a Giant Diffuse Plexiform Neurofibroma Invading the liver.
Yokogawa Y; Suzuki T; Suzuki H; Nemoto R; Shimizu H; Ueda T; Uchihara D; Okubo Y; Ichii O; Tai M; Ejiri Y; Harada M
Intern Med; 2023 Oct; 62(20):2971-2975. PubMed ID: 36792186
[TBL] [Abstract] [Full Text] [Related]
4. Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.
Yokoo T; Masaki N; Parikh ND; Lane BF; Feng Z; Mendiratta-Lala M; Lee CH; Khatri G; Marsh TL; Shetty K; Dunn CT; Al-Jarrah T; Aslam A; Davenport MS; Gopal P; Rich NE; Lok AS; Singal AG
Radiology; 2023 Apr; 307(2):e220917. PubMed ID: 36692401
[TBL] [Abstract] [Full Text] [Related]
5. Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma.
Shi DM; Dong SS; Zhou HX; Song DQ; Wan JL; Wu WZ
Cell Signal; 2023 Apr; 104():110565. PubMed ID: 36539000
[TBL] [Abstract] [Full Text] [Related]
6. Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.
Chen S; Guan L; Zhao X; Yang J; Chen L; Guo M; Zhao J; Chen C; Zhou Y; Han Y; Xu L
J Zhejiang Univ Sci B; 2022 Nov; 23(11):915-930. PubMed ID: 36379611
[TBL] [Abstract] [Full Text] [Related]
7. Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma.
Rimini M; Fabregat-Franco C; Burgio V; Lonardi S; Niger M; Scartozzi M; Rapposelli IG; Aprile G; Ratti F; Pedica F; Verdaguer H; Rizzato M; Nichetti F; Lai E; Cappetta A; Macarulla T; Fassan M; De Braud F; Pretta A; Simionato F; De Cobelli F; Aldrighetti L; Fornaro L; Cascinu S; Casadei-Gardini A
Sci Rep; 2022 Nov; 12(1):18775. PubMed ID: 36335135
[TBL] [Abstract] [Full Text] [Related]
8. Pheochromocytoma Turned Malignant During Pregnancy in a Patient With Neurofibromatosis Type I - A Case Report and Systematic Review of the Current Literature.
Zeitler C; Fuderer L; Schmitz K; Arora R; Dammerer D
Anticancer Res; 2022 Sep; 42(9):4647-4656. PubMed ID: 36039448
[TBL] [Abstract] [Full Text] [Related]
9. Neurofibromatosis Type 1: A Rare Predisposition for Gastrinomas and Other Neuroendocrine Tumors.
Gauci J; Azzopardi N; Babic D; Cortis K; Axisa B
Pancreas; 2022 May; 51(5):559-562. PubMed ID: 35973017
[TBL] [Abstract] [Full Text] [Related]
10. Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study.
Niger M; Nichetti F; Casadei-Gardini A; Rizzato MD; Pircher C; Bini M; Franza A; Rimini M; Burgio V; Sposetti C; Fornaro L; Rapposelli IG; D'Amico FE; Aprile G; Vivaldi C; Frassineti GL; Milione M; Leoncini G; Cappetta A; Vasile E; Fassan M; Morano F; Perrone F; Tamborini E; Pruneri G; Lonardi S; Mazzaferro V; Pietrantonio F; Di Bartolomeo M; de Braud F
Int J Cancer; 2022 Oct; 151(8):1310-1320. PubMed ID: 35723131
[TBL] [Abstract] [Full Text] [Related]
11. Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.
Coto-Llerena M; Benjak A; Gallon J; Meier MA; Boldanova T; Terracciano LM; Ng CKY; Piscuoglio S
JCO Precis Oncol; 2022 Mar; 6():e2100335. PubMed ID: 35263170
[TBL] [Abstract] [Full Text] [Related]
12. Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern.
Chung T; Rhee H; Shim HS; Yoo JE; Choi GH; Kim H; Park YN
Gut Liver; 2022 Jul; 16(4):613-624. PubMed ID: 34810298
[TBL] [Abstract] [Full Text] [Related]
13. Identification of driver genes and target drugs-related genes in liver cancer based on targeted next generation sequencing.
Cui Y; Sun L; Wang H; Zhang Z; Dai H; Liu P
Neoplasma; 2022 Jan; 69(1):95-102. PubMed ID: 34704453
[TBL] [Abstract] [Full Text] [Related]
14. Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas.
Schalkwijk S; Zhou L; Cohen-Rabbie S; Jain L; Freshwater T; So K; He Z; Gioni I; Tomkinson H; Vishwanathan K; Zhou D
Cancer Chemother Pharmacol; 2021 Aug; 88(2):189-202. PubMed ID: 33903938
[TBL] [Abstract] [Full Text] [Related]
15. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
16. Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: a nationwide cancer-registry-based study.
Chu SS; Kuo YH; Liu WS; Wang SC; Ho CH; Chen YC; Yang CC; Wu HC
Sci Rep; 2021 Jan; 11(1):1614. PubMed ID: 33452421
[TBL] [Abstract] [Full Text] [Related]
17. Periportal Plexiform Neurofibromatosis; a rare intra-abdominal manifestation of nf1.
Siddique K; Sipra ZS
J Pak Med Assoc; 2020 Mar; 70(3):557-558. PubMed ID: 32207449
[TBL] [Abstract] [Full Text] [Related]
18. Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report.
Brock P; Bustamante Alvarez J; Mortazavi A; Roychowdhury S; Phay J; Khawaja RA; Shah MH; Konda B
Fam Cancer; 2020 Apr; 19(2):189-192. PubMed ID: 32052251
[TBL] [Abstract] [Full Text] [Related]
19. Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform cancer Therapy.
Vasmatzis G; Liu MC; Reganti S; Feathers RW; Smadbeck J; Johnson SH; Schaefer Klein JL; Harris FR; Yang L; Kosari F; Murphy SJ; Borad MJ; Thompson EA; Cheville JC; Anastasiadis PZ
Mayo Clin Proc; 2020 Feb; 95(2):306-318. PubMed ID: 31685261
[TBL] [Abstract] [Full Text] [Related]
20. Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.
Kaseb AO; Sánchez NS; Sen S; Kelley RK; Tan B; Bocobo AG; Lim KH; Abdel-Wahab R; Uemura M; Pestana RC; Qiao W; Xiao L; Morris J; Amin HM; Hassan MM; Rashid A; Banks KC; Lanman RB; Talasaz A; Mills-Shaw KR; George B; Haque A; Raghav KPS; Wolff RA; Yao JC; Meric-Bernstam F; Ikeda S; Kurzrock R
Clin Cancer Res; 2019 Oct; 25(20):6107-6118. PubMed ID: 31363003
[TBL] [Abstract] [Full Text] [Related]
[Next]
